Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism αIIbβ3 inhibitors(Integrin αIIbβ3 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H19N7O2S |
InChIKeyITNCYPYTFKVCFI-UHFFFAOYSA-N |
CAS Registry1355454-05-5 |